Glucotrol: profile and news






Local ties assist new Pfizer drug  Feb 20, 2006
About 20 companies were identified as potential partners including Pfizer, which markets the oral anti-diabetic drug, Glucotrol, and was interested in ... - MSNBC

Pfizer's Exubera(R): A Unique Background Perspective  Jan 27, 2006
Pfizer, who marketed the oral anti-diabetic drug, Glucotrol® (glipizide), was interested in extending its diabetes franchise into insulin. ... - Market Wire (press release)

Andrx Corporation Reports 2005 Third Quarter Results  Nov 8, 2005
The decrease is primarily due to decreases from our generic versions of Glucotrol XL(R), supplied by Pfizer, OTC Claritin-D(R) 24, K-Dur(R) and Glucophage(R ... - PharmaLive.com (press release),

Karen A. Dawes Elected a Director of Repligen Corporation  Sep 15, 2005
Ms. Dawes has directed the launch of numerous pharmaceuticals including Glucotrol/Glucotrol XL(R), Zoloft(R), and Cardura(R) for Pfizer. ... - PR Newswire (press release),

FDA panel backs drug for Type 2 diabetes  Sep 12, 2005
...panel also voted 6 to 3 to reject approval of Pagluva when combined with sulfonylurea, another popular diabetes drugs sold under the names Amaryl and Glucotrol ... - Monsters and Critics.com,

New drug can reduce blood sugar  Sep 19, 2005
Low blood sugars may also occur if the patient is taking medications known as sulfonylureas such as Glucotrol, Glynase or Amaryl. ... - Rocky Mount Telegram,

Many meds don't mix with the sun  Sep 21, 2005
Antidiabetic agents: Acetohexamide (Dymelor), chlorpro-pamide (Diabinese), glimepiride (Amaryl), glipizide (Glucotrol), glyburide (DiaBeta, Micronase ... - Pioneer Press,

'A LIFE SAVER': PROGRAM MAKES DRUGS MORE AVAILABLE  Aug 19, 2005
The majority of the drugs patients received included Norvasc, a blood pressure medicine; Lipitor, a cholesterol medicine; and Glucotrol XL, which controls ... - Pine Bluff Commercial,

A TRUSS CAN BE A TEMPORARY FIX FOR A HERNIA  Jul 23, 2005
DEAR DR. DONOHUE: My friend has type-2 diabetes and takes Glucotrol for it. There is a warning on the label not to drink alcohol while taking this medicine. ... - Charlotte Sun-Herald

Should cancer patient wear truss for hernia?  Jul 28, 2005
I would, however, check out the possibility that your lower back pain is not due to the fibroid. Q:My friend has Type 2 diabetes and takes Glucotrol for it. ... - The Republican <**results**>

Top 10 Things to Know About Diabetes Pills  Jul 4, 2005
Sulfonylureas of the second generation are glipizide (brand names Glucotrol and Glucotrol XL), glyburide (Micronase, Glynase, and Diabeta), and glimepiride ... - About Diabetes

A prescription for helping  Jun 28, 2005
...pressure. Eighteen Pfizer medicines, including Celebrex, Glucotrol XL, Lipitor, Viagra, Zyrtec and Zoloft, will be available. To ... - Wilson Daily Times (subscription),

Daily drug regimen of Alice and Ken Heckman  Apr 16, 2005
Reduces high blood sugar in diabetics. 3) Glucotrol, glipizide. Another diabetes drug that stimulates the pancreas to release more insulin. ... - New York Newsday

Industry's biggest manufacturers enter generics through loophole  Apr 10, 2005
Andrx, for example, makes an authorized version of Pfizer's Glucotrol XL for diabetes, while Ivax has an agreement to launch an authorized copy of Pfizer's ... - Sun-Sentinel.com,

BCBSNC Launches New Prescription Drug Savings Initiative  Feb 17, 2005
...quinapril/HCTZ (generic Accuretic) ORAL AGENTS FOR DIABETES (Drugs to Treat Non-Insulin Dependent Diabetes) glipizide (generic Glucotrol) glipizide ER (generic ... - PR Newswire (press release)


Other information


Indication
For the treatment of hyperglycemia in Non-insulin-dependent diabetes mellitus (NIDDM)

Pharmacology
Glipizide, a second-generation sulfonylurea, is used with diet to lower blood glucose in patients with diabetes mellitus type II.

Mechanism Of Action
Sulfonylureas likely bind to ATP-sensitive potassium-channel receptors on the pancreatic cell surface, reducing potassium conductance and causing depolarization of the membrane. Depolarization stimulates calcium ion influx through voltage-sensitive calcium channels, raising intracellular concentrations of calcium ions, which induces the secretion, or exocytosis, of insulin.

Drug Category
Hypoglycemic Agents; ATC:A10BB07

Brand Names/Synonyms
AC-120; Aldiab; Apamid; CHEMBANK72; Digrin; Dipazide; G117; Glibenese; Glibetin; Glican; Glide; Glidiab; Glipid; Glipizida [Inn-Spanish]; Glipizide; Glipizide Extended-Release Tablets; Glipizide [Usan:Ban:Inn]; Glipizidum [Inn-Latin]; Gluco-Rite; Glucolip; Glucotrol; Glucotrol Xl; Glucozide; Glupitel; Glupizide; Glyde; Glydiazinamide; K 4024; Melizide; Metaglip; Mindiab; Minidab; Minidiab; Minodiab; Napizide; Ozidia; Sucrazide; TK 1320

Dosage Forms
IR oral tablets and ER oral tablets

Absorption
uniform, rapid, and essentially complete

Interactions
-->Interactions for Glipizide:

Immediate and Extended Release Tablets

The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents. When such drugs are administered to a patient receiving glipizide, the patient should be observed closely for hypoglycemia. When such drugs are withdrawn from a patient receiving glipizide, the patient should be observed closely for loss of control. In vitro binding studies with human serum proteins indicate that glipizide binds differently than tolbutamide and does not interact with salicylate or dicumarol. However, caution must be exercised in extrapolating these findings to the clinical situation and in the use of glipizide with these drugs.

Certain drugs tend to produce hyperglycemia and may lead to loss of control. These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid. When such drugs are administered to a patient receiving glipizide, the patient should be closely observed for loss of control. When such drugs are withdrawn from a patient receiving glipizide, the patient should be observed closely for hypoglycemia.

A potential interaction between oral miconazole and oral hypoglycemic agents leading to severe hypoglycemia has been reported. Whether this interaction also occurs with the intravenous, topical, or vaginal preparations of miconazole is not known. The effect of concomitant administration of fluconazole and glipizide has been demonstrated in a placebo-controlled crossover study in normal volunteers. All subjects received glipizide alone and following treatment with 100 mg of fluconazole as a single daily oral dose for seven days. The mean percentage increase in the glipizide AUC after fluconazole administration was 56.9% (range: 35 to 81).



Chemical IUPAC Name
N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-pyridine-2-carboxamide

Chemical Formula
C22H28N4O4S

Half Life
2-4 hours

Drug Type
Approved Drug

# Accession No
APRD00436

CAS Registry Number
29094-61-9

Home | About | Cancers | Treatment | Medications
Copyright onconews.org 2005.
All Rights Reserved.
Google
 
Web onconews.org